Skip to content

A 4852 · New Jersey · 222 · Billy

Skip to content

Home
/
Bills
/
New Jersey
/
222
/
A 4852

New Jersey · 222 session · house

A 4852Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Status: Passed chamber
Latest action: 2026-07-08 — Approved P.L.2026, c.40.
Primary sponsor: Katz, Andrea (Democratic)

Bills and Joint Resolutions Signed by the Governor

Track this bill View changes+323 / −397 words · Large

Sponsors

Katz, Andrea (Democratic) · primaryprimary
Sweeney, Marisa

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New Jersey bill RSS

(Democratic)

· primary

primary

KMKearney, Vincent M. · primaryprimary

TCTully, Chris (Democratic) · primaryprimary

VFVitale, Joseph F. (Democratic) · primaryprimary

GVGopal, Vin (Democratic) · primaryprimary

MRMukherji, Raj (Democratic) · primaryprimary

KJKarabinchak, Robert J. (Democratic) · cosponsor

DMDonlon, Margie, M.D. · cosponsor

Versions

IntroducedMay 4, 2026
Assembly Committee Substitute—
Statement—
Advance Law—
Pamphlet Law—

Legislative history

Jul 8, 2026
Approved P.L.2026, c.40.
Jun 30, 2026
Received in the Senate without Reference, 2nd Reading
Jun 30, 2026
Substituted for S4194/4210 (SCS)
Jun 30, 2026
Passed by the Assembly (76-2-1)
Jun 30, 2026
Passed Senate (Passed Both Houses) (38-2)
Jun 23, 2026
Reported from Assembly Comm. as a Substitute, 2nd Reading
Jun 23, 2026
Transferred to Assembly State and Local Government Committee
May 4, 2026
Introduced, Referred to Assembly Health Committee

Official sources

Version 0PDF HTML
Version 1PDF HTML
Version 2PDF HTML
Version 3PDF HTML
Version 4PDF HTML

About this page

Is this the official New Jersey bill page?: No — this is Billy’s public legislative record for A 4852. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track A 4852, get alerts, annotate diffs, and export Word work product.